Bell Investment Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.7K | Buy |
200
+44
| +28% | +$4.33K | ﹤0.01% | 428 |
|
2025
Q1 | $14.5K | Buy |
156
+31
| +25% | +$2.87K | ﹤0.01% | 479 |
|
2024
Q4 | $11.3K | Buy |
125
+28
| +29% | +$2.54K | ﹤0.01% | 556 |
|
2024
Q3 | $9.36K | Sell |
97
-7
| -7% | -$676 | ﹤0.01% | 652 |
|
2024
Q2 | $9.55K | Buy |
104
+26
| +33% | +$2.39K | ﹤0.01% | 630 |
|
2024
Q1 | $7.19K | Hold |
78
| – | – | ﹤0.01% | 725 |
|
2023
Q4 | $7.42K | Buy |
78
+31
| +66% | +$2.95K | ﹤0.01% | 679 |
|
2023
Q3 | $4.39K | Sell |
47
-7
| -13% | -$654 | ﹤0.01% | 875 |
|
2023
Q2 | $4.94K | Buy |
54
+24
| +80% | +$2.2K | ﹤0.01% | 832 |
|
2023
Q1 | $2.21K | Buy |
30
+9
| +43% | +$662 | ﹤0.01% | 1211 |
|
2022
Q4 | $1.75K | Buy |
21
+10
| +91% | +$835 | ﹤0.01% | 1358 |
|
2022
Q3 | $1K | Sell |
11
-8
| -42% | -$727 | ﹤0.01% | 1301 |
|
2022
Q2 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 1082 |
|
2021
Q4 | $2K | Buy |
14
+5
| +56% | +$714 | ﹤0.01% | 1085 |
|
2021
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1246 |
|